PolarityTE Inc.


PolarityTE Inc. Stock Quote
$0.71 $0.01 0.9%
Price as of December 2, 2020, 9:00 p.m. EST View Interactive PTE Charts

commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patients own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patients own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patients own tissue and uses the patients own body to support the regenerative process to create the same tissue from which it was derived. PolarityTEs innovative method is intended to promote and accelerate growth of the patients tissues to undergo a form of effective regenerative healing.

Interactive Chart

News & Analysis: PolarityTE Inc.


Market Moves

Is Co-Diagnostics Stock a Buy?

The company's stock had a huge week after announcing that Arches Research has signed a deal to use its coronavirus test kit.

Why PolarityTE Is Sinking Today

Shares drop after the company announces that it is raising capital. Here are the must-know details for investors.